- Home
- KELYA vs MAZE Comparison
KELYA vs MAZE Comparison
Compare KELYA & MAZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KELYA
- MAZE
- Stock Information
- Founded
- KELYA 1946
- MAZE 2018
- Country
- KELYA United States
- MAZE United States
- Employees
- KELYA N/A
- MAZE N/A
- Industry
- KELYA Professional Services
- MAZE
- Sector
- KELYA Consumer Discretionary
- MAZE
- Exchange
- KELYA Nasdaq
- MAZE NYSE
- Market Cap
- KELYA 403.0M
- MAZE 367.0M
- IPO Year
- KELYA N/A
- MAZE 2025
- Fundamental
- Price
- KELYA $11.72
- MAZE $10.01
- Analyst Decision
- KELYA Buy
- MAZE Strong Buy
- Analyst Count
- KELYA 1
- MAZE 3
- Target Price
- KELYA $25.00
- MAZE $25.67
- AVG Volume (30 Days)
- KELYA 296.3K
- MAZE 104.1K
- Earning Date
- KELYA 05-08-2025
- MAZE 05-14-2025
- Dividend Yield
- KELYA 2.56%
- MAZE N/A
- EPS Growth
- KELYA N/A
- MAZE N/A
- EPS
- KELYA N/A
- MAZE 0.34
- Revenue
- KELYA $4,451,600,000.00
- MAZE $167,500,000.00
- Revenue This Year
- KELYA $9.31
- MAZE N/A
- Revenue Next Year
- KELYA $4.14
- MAZE N/A
- P/E Ratio
- KELYA N/A
- MAZE $29.84
- Revenue Growth
- KELYA N/A
- MAZE N/A
- 52 Week Low
- KELYA $10.80
- MAZE $6.71
- 52 Week High
- KELYA $23.81
- MAZE $17.00
- Technical
- Relative Strength Index (RSI)
- KELYA 45.63
- MAZE N/A
- Support Level
- KELYA $11.37
- MAZE N/A
- Resistance Level
- KELYA $12.08
- MAZE N/A
- Average True Range (ATR)
- KELYA 0.33
- MAZE 0.00
- MACD
- KELYA -0.04
- MAZE 0.00
- Stochastic Oscillator
- KELYA 24.14
- MAZE 0.00
About KELYA Kelly Services Inc.
Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.
About MAZE MAZE THERAPEUTICS INC
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.